.svg){kind=icon}
+91-9660032889
support@mysiponline.com
-
₹499.19
(0.92%)
Current NAV 19-11-2024
-
34.98%
Returns
-
Min. SIP ₹500
Min. Investment ₹5000
Fund Suitability Test
Asset Allocation (As on 31-Oct-2024)
Allocation of Equity and Debt Asset Classes.
- Equity 95.6%
Market Cap Allocation Of Equity
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Large Cap | 45.96 |
| Mid Cap | 27.12 |
| Small Cap | 22.52 |
Sector Allocation of Equity
Weightage of Portfolio Among Different Sectors.
Pharmaceuticals & Biotechnology
Healthcare Services
Retailing
Current Stocks Holdings of Equity
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 21-Nov-2024 |
Holdings | PE Ratio 21-Nov-2024 |
1Y Return |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Large Cap | Pharmaceuticals & Biotechnology (47.24) | 13.95% | 38.46 | 47.42% |
| Divis Laboratories Limited | Large Cap | Pharmaceuticals & Biotechnology (47.24) | 9.16% | 86.18 | 60.17% |
| Lupin Limited | Mid Cap | Pharmaceuticals & Biotechnology (132.95) | 8.06% | 167.31 | 197.56% |
| Cipla Limited | Large Cap | Pharmaceuticals & Biotechnology (47.24) | 5.54% | 26.4 | 16.68% |
| Apollo Hospitals Enterprise Limited | Large Cap | Healthcare Services (91.51) | 5.24% | 81.88 | 23.31% |
| Dr. Reddys Laboratories Limited | Large Cap | Pharmaceuticals & Biotechnology | 5.13% | - | 0% |
| Vijaya Diagnostic Centre Limited | Small Cap | Healthcare Services (91.51) | 3.48% | 87.5 | 82.34% |
| Ajanta Pharma Limited | Mid Cap | Pharmaceuticals & Biotechnology (47.24) | 3.38% | 41.94 | 48.91% |
| JB Chemicals & Pharmaceuticals Limited | Small Cap | Pharmaceuticals & Biotechnology (55.16) | 2.89% | 48.39 | 61.86% |
| Abbott India Limited | Mid Cap | Pharmaceuticals & Biotechnology (47.24) | 2.88% | 0 | 13.65% |
| Gland Pharma Limited | Mid Cap | Pharmaceuticals & Biotechnology (47.24) | 2.85% | 42.61 | 7.9% |
| Mankind Pharma Limited | Large Cap | Pharmaceuticals & Biotechnology (47.24) | 2.77% | 48.52 | 31.75% |
| Aurobindo Pharma Limited | Mid Cap | Pharmaceuticals & Biotechnology (47.24) | 2.74% | 19.77 | 18.72% |
| GlaxoSmithKline Pharmaceuticals Limited | Mid Cap | Pharmaceuticals & Biotechnology (47.24) | 2.6% | 59.64 | 43.25% |
| MedPlus Health Services Limited | Small Cap | Retailing (47.24) | 2.36% | 88 | -11.86% |
| Zydus Lifesciences Limited | Large Cap | Pharmaceuticals & Biotechnology (47.24) | 2.31% | 21.36 | 47.43% |
| Narayana Hrudayalaya Limited | Small Cap | Healthcare Services (91.51) | 2.2% | 33.04 | 0.03% |
| Thyrocare Technologies Limited | Small Cap | Healthcare Services (91.51) | 1.9% | 60.96 | 77.39% |
| Pfizer Limited | Small Cap | Pharmaceuticals & Biotechnology (47.24) | 1.87% | 0 | 26.66% |
| Torrent Pharmaceuticals Limited | Large Cap | Pharmaceuticals & Biotechnology (47.24) | 1.86% | 58.33 | 46.54% |
| Alkem Laboratories Limited | Mid Cap | Pharmaceuticals & Biotechnology (38.82) | 1.85% | 57.92 | -8.63% |
| Sanofi India Limited | Small Cap | Pharmaceuticals & Biotechnology (24.65) | 1.8% | 8.73 | 145.06% |
| Fortis Healthcare Limited | Mid Cap | Healthcare Services (91.51) | 1.65% | 78.25 | 82.77% |
| Sanofi Consumer Healthcare India Limited | Small Cap | Pharmaceuticals & Biotechnology | 1.21% | - | 0% |
| Syngene International Limited | Mid Cap | Healthcare Services (70.97) | 1.11% | 70.81 | 17.35% |
| Orchid Pharma Limited | Small Cap | Pharmaceuticals & Biotechnology (47.24) | 1.05% | 62.46 | 159.4% |
| Dr. Lal Path Labs Limited | Small Cap | Healthcare Services (91.51) | 1.04% | 63.03 | 11.65% |
| Indoco Remedies Limited | Small Cap | Pharmaceuticals & Biotechnology (47.24) | 0.66% | 86.06 | -14.62% |
| AstraZeneca Pharma India Limited | Small Cap | Pharmaceuticals & Biotechnology (55.16) | 0.56% | 96.24 | 61.67% |
| Emcure Pharmaceuticals Limited | Small Cap | Pharmaceuticals & Biotechnology | 0.5% | - | 0% |
| Healthcare Global Enterprises Limited | Small Cap | Healthcare Services (91.51) | 0.47% | 114.49 | 26.79% |
| Krishna Institute Of Medical Sciences Limited | Small Cap | Healthcare Services | 0.29% | - | 0% |
| Concord Biotech Limited | Small Cap | Pharmaceuticals & Biotechnology (55.16) | 0.24% | 50.34 | 0% |
Discover More with Premium Access
View Stock Information
Take test again
Chat with usFrequently Asked Questions
What is Market cap allocation in the portfolio?
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.
Top 5 holdings for Nippon India Pharma Fund?
The top holdings of this fund are
How do I create a good mutual fund portfolio?
Building a good portfolio requires proper research and knowing about goals that need to be achieved. Set a boundary for your risk capacity, study about different funds and look at its past performance. Balance portfolio according to set goals and stay informed.
How to maintain a good portfolio?
Timely monitoring of the portfolio keeps us aware of the changes in the ongoing market trends. It helps in making plans for any policy change.
What is sector allocation in the portfolio?
The distribution of assets among various economic sectors is referred to as sector allocation in a portfolio. These sectors include technology, healthcare, financial, energy, and many others.
Top 5 Sector for Nippon India Pharma Fund?
The major sectors of this fund are .
What is the ideal number of funds to have in a portfolio?
There is no ideal number, but it is always advisable to keep 4-5 funds in the portfolio as it can be easy to manage them and correct decisions can be taken according to it. Diversification is the key to manage and balance your portfolio for smooth growth.
How does risk tolerance play a role in determining portfolio allocation?
Risk tolerance is an important factor in maintaining portfolio allocation. With the correct mix of assets, the value of investments can improve significantly.